Abbott Laboratories (ABT) NYSE

132.65

+3.29(+2.54%)

Updated at September 11 04:00PM

Currency In USD

Valuation

Market Cap195.87B
Enterprise Value203.53B
P/E Ratio16.52
PEG Ratio4.77
Price/Sales Ratio5.36
Price/Book Ratio4.57
Enterprise/Revenue5.51
Enterprise/EBITDA20.44

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.32
Operating Margin0.18

Management Effectiveness

Return On Assets0.17
Return On Equity0.3

Income Statement

Revenue41.95B
Revenue/Share24.77
Gross Profit21.33B
EBITDA10.83B
Net Income13.4B
Diluted EPS7.64

Balance Sheet

Total Cash7.28B
Total Cash/Share4.18
Total Debt13.44B
Total Debt/Equity0.27
Current Ratio1.82
Book Value Per Share29.2

Price History

52-Week Change13.77
52-Week High141.23
52-Week Low110.86
Moving Average 50 Days130.44
Moving Average 200 Days127.9

Statistics

Average Volume6.39M
Shares Outstanding1.74B
% Held by Institutions75.69

Dividend And Splits

Trailing Annual Dividend Rate2.32
Trailing Annual Dividend Yield1.75
Payout Ratio0.28
Last Split Factor5000:2399
Last Split DateJanuary 02, 2013